Nova Patents
EP1524264A3

2-ethylidene-19-nor-vitamin D compounds

Abstract

Biologically active 19-nor vitamin D analogs substituted at C-2 in the A-ring with an ethylidene group. These compounds have preferential activity on mobilising calcium from bone and either high or normal intestinal calcium transport activity which allows their in vivo administration for the treatment of metabolic bone diseases where bone loss is a major concern. These compounds are also characterised by high cell differentiation activity.

Term

Term ended

Projected expiry passed 31 May 2021, 5.3 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

Every citation, both ways

Citations
DocumentRelationOfficeCategoryCited duringRelevant claims
WO9841500A1CitesWorld Intellectual Property Organization (WIPO)YSearch report1-28
R.R. SICINSKI ET AL, J. MED. CHEM, vol. 41, no. 23, 1998, pages 4662 - 4674, XP002526359Non-patent––Search report–